These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32319569)
1. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569 [TBL] [Abstract][Full Text] [Related]
2. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer. Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633 [TBL] [Abstract][Full Text] [Related]
3. Identification of zinc finger MIZ-type containing 2 as an oncoprotein enhancing NAD-dependent protein deacetylase sirtuin-1 deacetylase activity to regulate Wnt and Hippo pathways in non-small-cell lung cancer. Gan X; Feng Y; Liu Y; Lin X; Yu X; Rong X; Han Q Cell Mol Biol Lett; 2024 Sep; 29(1):122. PubMed ID: 39266996 [TBL] [Abstract][Full Text] [Related]
4. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer. Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127 [TBL] [Abstract][Full Text] [Related]
5. m Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857 [TBL] [Abstract][Full Text] [Related]
6. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723 [TBL] [Abstract][Full Text] [Related]
7. m Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells. You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway. Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
11. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. Machado-Neto JA; Lazarini M; Favaro P; Franchi GC; Nowill AE; Saad ST; Traina F Exp Cell Res; 2014 Jun; 324(2):137-45. PubMed ID: 24726915 [TBL] [Abstract][Full Text] [Related]
12. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway. Li T; Guo T; Liu H; Jiang H; Wang Y Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116 [TBL] [Abstract][Full Text] [Related]
13. EIF4A3-Induced Upregulation of hsa_circ_0049396 Attenuates the Tumorigenesis of Nasopharyngeal Carcinoma by Regulating the Hippo-YAP Pathway. Zhou Q; Cai B; Liu K; Chen H DNA Cell Biol; 2024 Oct; 43(10):510-519. PubMed ID: 39133108 [TBL] [Abstract][Full Text] [Related]
14. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
15. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Han Y; Tang Z; Zhao Y; Li Q; Wang E Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138 [TBL] [Abstract][Full Text] [Related]
16. Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes. Almeida BO; Machado-Neto JA BMB Rep; 2020 Aug; 53(8):413-418. PubMed ID: 32635985 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1. Zhao W; Zhang LN; Wang XL; Zhang J; Yu HX FASEB J; 2019 Jan; 33(1):1151-1166. PubMed ID: 30148675 [TBL] [Abstract][Full Text] [Related]
18. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth. Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136 [TBL] [Abstract][Full Text] [Related]
19. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216 [TBL] [Abstract][Full Text] [Related]
20. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis. Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]